Cargando…

Computed Tomography-Based Quantitative Texture Analysis and Gut Microbial Community Signatures Predict Survival in Non-Small Cell Lung Cancer

SIMPLE SUMMARY: There is a lack of understanding of the pathogenesis and mechanisms accounting for the large variability in tumor response to immune checkpoint inhibition. In this study, we investigate the role and composition of the human gut microbiome in the clinical setting by integrating shotgu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dora, David, Weiss, Glen J., Megyesfalvi, Zsolt, Gállfy, Gabriella, Dulka, Edit, Kerpel-Fronius, Anna, Berta, Judit, Moldvay, Judit, Dome, Balazs, Lohinai, Zoltan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605408/ https://www.ncbi.nlm.nih.gov/pubmed/37894458 http://dx.doi.org/10.3390/cancers15205091

Ejemplares similares

Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 status
por: Dora, David, et al.
Publicado: (2023)

Distinct composition and metabolic functions of human gut microbiota are associated with cachexia in lung cancer patients
por: Ni, Yueqiong, et al.
Publicado: (2021)

Gut microbiome functionality might be associated with exercise tolerance and recurrence of resected early-stage lung cancer patients
por: Marfil-Sánchez, Andrea, et al.
Publicado: (2021)

Next-Generation Sequencing May Discriminate Extreme Long-term versus Short-term Survival in Patients with Metastatic Small Cell Lung Cancer (SCLC)
por: Lohinai, Zoltan, et al.
Publicado: (2019)

Candida expansion in the gut of lung cancer patients associates with an ecological signature that supports growth under dysbiotic conditions
por: Seelbinder, Bastian, et al.
Publicado: (2023)

From Bench to Bedside: Attempt to Evaluate Repositioning of Drugs in the Treatment of Metastatic Small Cell Lung Cancer (SCLC)
por: Lohinai, Zoltan, et al.
Publicado: (2016)

Neutrophil–lymphocyte ratio is prognostic in early stage resected small-cell lung cancer
por: Lohinai, Zoltan, et al.
Publicado: (2019)

Longitudinal analysis of complete blood count parameters in advanced‐stage lung cancer patients
por: Rojko, Livia, et al.
Publicado: (2020)

Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution
por: Dora, David, et al.
Publicado: (2020)

PD-1 and PD-L1 expression in rare lung tumors
por: Gyulai, Marton, et al.
Publicado: (2023)

Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis
por: Bogos, Krisztina, et al.
Publicado: (2021)

KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy
por: Ghimessy, Áron Kristof, et al.
Publicado: (2019)

BRAF RNA is prognostic and widely expressed in lung adenocarcinoma
por: Dora, David, et al.
Publicado: (2023)

The effects of bisphosphonate and radiation therapy in bone-metastatic lung adenocarcinoma: the impact of KRAS mutation
por: Radeczky, Peter, et al.
Publicado: (2021)

Significant changes in advanced lung cancer survival during the past decade in Hungary: impact of modern immunotherapy and the COVID-19 pandemic
por: Kiss, Zoltán, et al.
Publicado: (2023)

EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter study
por: Gieszer, Balazs, et al.
Publicado: (2021)

Bone-Specific Metastasis Pattern of Advanced-Stage Lung Adenocarcinoma According to the Localization of the Primary Tumor
por: Radeczky, Peter, et al.
Publicado: (2021)

The landscape of small cell lung cancer metastases: Organ specificity and timing
por: Megyesfalvi, Zsolt, et al.
Publicado: (2021)

KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis
por: Lohinai, Zoltan, et al.
Publicado: (2017)

Characterization of Tumor-Associated Macrophages and the Immune Microenvironment in Limited-Stage Neuroendocrine-High and -Low Small Cell Lung Cancer
por: Dora, David, et al.
Publicado: (2021)

A robust prognostic gene expression signature for early stage lung adenocarcinoma
por: Krzystanek, Marcin, et al.
Publicado: (2016)

High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma
por: Hoda, Mir Alireza, et al.
Publicado: (2016)

ELECTRON MICROSCOPE HISTOCHEMICAL EVIDENCE FOR A PARTIAL OR TOTAL BLOCK OF THE TRICARBOXYLIC ACID CYCLE IN THE MITOCHONDRIA OF PRESYNAPTIC AXON TERMINALS
por: Hajós, Ferenc, et al.
Publicado: (1971)

Apelin promotes blood and lymph vessel formation and the growth of melanoma lung metastasis
por: Berta, Judit, et al.
Publicado: (2021)

SALT AND WATER LOSSES IN DIURETIN DIURESIS AND THEIR RELATION TO SERUM NON-PROTEIN NITROGEN AND ELECTROLYTE CONCENTRATIONS
por: Kerpel-Fronius, Edmond, et al.
Publicado: (1935)

Expression patterns and prognostic relevance of subtype‐specific transcription factors in surgically resected small‐cell lung cancer: an international multicenter study
por: Megyesfalvi, Zsolt, et al.
Publicado: (2022)

Oncofetal Chondroitin Sulfate Is a Highly Expressed Therapeutic Target in Non-Small Cell Lung Cancer
por: Oo, Htoo Zarni, et al.
Publicado: (2021)

A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures
por: Diossy, Miklos, et al.
Publicado: (2021)

Lung cancer drug therapy in Hungary – 3-year experience
por: Moldvay, Judit, et al.
Publicado: (2015)

Current therapy of KRAS-mutant lung cancer
por: Ghimessy, Aron, et al.
Publicado: (2020)

Oncobiosis and Microbial Metabolite Signaling in Pancreatic Adenocarcinoma
por: Kiss, Borbála, et al.
Publicado: (2020)

Editorial: Grand Challenges in Pharmaceutical Medicine: Competencies and Ethics in Medicines Development
por: Silva, Honorio, et al.
Publicado: (2021)

Malignant pleural mesothelioma nodules remodel their surroundings to vascularize and grow
por: Kovacs, Ildiko, et al.
Publicado: (2022)

Massive Withdrawal Symptoms and Affective Vulnerability Are Associated with Variants of the CHRNA4 Gene in a Subgroup of Smokers
por: Lazary, Judit, et al.
Publicado: (2014)

Editorial: Reviews in: regulatory science
por: Kerpel-Fronius, Sandor, et al.
Publicado: (2023)

Utilization of genetic information for medicines development and equitable benefit sharing
por: Matsuyama, Kotone, et al.
Publicado: (2023)

Revising Incidence and Mortality of Lung Cancer in Central Europe: An Epidemiology Review From Hungary
por: Bogos, Krisztina, et al.
Publicado: (2019)

Claudin expression in pulmonary adenoid cystic carcinoma and mucoepidermoid carcinoma
por: Gyulai, Marton, et al.
Publicado: (2023)

Nonsuicidal Self-Injury and Perfectionism: A Systematic Review
por: Gyori, Dora, et al.
Publicado: (2021)

Third-generation Sequencing Reveals Extensive Polycistronism and Transcriptional Overlapping in a Baculovirus
por: Moldován, Norbert, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0j17tqith603lv6nsk5a6jviog